Effect of ruthenium complexes on the activities of succinate dehydrogenase and cytochrome oxidase

Chemico-Biological Interactions

Volumn 170, Issue 1, 2007, Pages 59-66

  Victor, Eduardo G ^a   Zanette, Francine ^a   Aguiar, Maira R ^a   Aguiar, Claudia S ^a   Cardoso, Danon C ^a   Cristiano, Maykon P ^a   Streck, Emilio L ^a   Paula, Marcos M S ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Cytochrome oxidase; Mitochondria; Ruthenium; Succinate dehydrogenase

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; CYTOCHROME C OXIDASE; MITOCHONDRIAL ENZYME; PYRIDINE DERIVATIVE; RUTHENIUM COMPLEX; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME INHIBITION; HEART; HIPPOCAMPUS; IN VITRO STUDY; KIDNEY; LIVER; MALE; NONHUMAN; RAT; SKELETAL MUSCLE;

ANIMALS; BRAIN; ELECTRON TRANSPORT COMPLEX IV; ENZYME ACTIVATION; KIDNEY; LIVER; MALE; MUSCLE, SKELETAL; MYOCARDIUM; NICOTINIC ACIDS; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; RUTHENIUM; SUCCINATE DEHYDROGENASE;

RATTUS;

EID: 34548588771     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.07.001     Document Type: Article

References (33)

1. 4] (dinic = 3,5-pyridinecarboxylic acid). J. Coord. Chem. 46 (1999) 491-504
2. Beirith A., Creczynski-Pasa T.B., Bonetti V.R., Konzen M., Seifriz I., Paula M.S., Franco C.V., and Calixto J.B. Antinociceptive properties and nitric oxide synthase inhibitory action of new ruthenium complexes. Eur. J. Pharmacol. 369 (1999) 289-297
3. 4] (dinic = 3,5-pyridinecarboxylic acid). J. Inorg. Biochem. 76 (1999) 153-163
4. 4] as free radical scavengers. J. Inorg. Biochem. 86 (2001) 587-594
5. Paula M.M.S., Pich C.T., Petronilho F., Drei L.B., Rudnicki M., Oliveira M.R., Moreira J.C.F., Henriques J.A.P., Franco C.V., and Dal-Pizzol F. Antioxidant activity of new ruthenium compounds. Redox Rep. 10 (2005) 139-143
6. Bergamo A., Stocco G., Casarsa C., Cocchietto M., Alessio E., Serli B., Zorzet S., and Sava G. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. Int. J. Oncol. 24 (2004) 373-379
7. Bergamo A., Stocco G., Gava B., Cocchietto M., Alessio E., Serli B., Iengo E., and Sava G. Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. J. Pharmacol. Exp. Ther. 305 (2003) 725-732
8. 4(DMSO)Im]: mechanism of the selective action investigated on mouse tumors. Anticancer Drugs 10 (1999) 129-138
9. Sava G., Capozzi I., Bergamo A., Gagliardi R., Cocchietto M., Masiero L., Onisto M., Alessio E., Mestroni G., and Garbisa S. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex. Int. J. Cancer 68 (1996) 60-66
10. Carballo M., Vilaplana R., Marquez G., Conde M., Bedoya F.J., Gonzalez-Vilchez F., and Sobrino F. A newly synthesized molecule derived from ruthenium cation, with antitumour activity, activates NADPH oxidase in human neutrophils. Biochem. J. 328 (1997) 559-564
11. Galeano A., Berger M.R., and Keppler B.K. Antitumor activity of some ruthenium derivatives in human colon cancer cell lines in vitro. Arzneimittelforschung 42 (1992) 821-824
12. 2]Cl on the isolated ischaemic-reperfused rat heart. Fundam. Clin. Pharmacol. 9 (1995) 545-553
13. 2+ (actatp = acenaphthereno[1,2-b]-1,4,8,9-tetraazariphenylene). J. Inorg. Biochem. 97 (2003) 207-214
14. Zhao M., and Clarke M.J. Effects of trans-pyridine ligands on the interactions of RuII and RuIII amine complexes N7-coordinated to purine nucleosides and DNA. J. Biol. Inorg. Chem. 4 (1999) 325-340
15. Trynda-Lemiesz L., Keppler B.K., and Kozlowski H. Studies on the interactions between human serum albumin and imidazolium [trans-tetrachlorobis(imidazol)ruthenate(III)]. J. Inorg. Biochem. 73 (1999) 123-128
16. Gonzalez-Vilchez F., Vilaplana R., Blasco G., and Messori L. Solution studies of the antitumor complex dichloro-1,2-propylendiaminetetraacetate ruthenium (III) and of its interactions with proteins. J. Inorg. Biochem. 71 (1998) 45-51
17. Fricker S.P., Slade E., Powell N.A., Vaughan O.J., Henderson G.R., Murrer B.A., Megson I.L., Bisland S.K., and Flitney F.W. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Br. J. Pharmacol. 122 (1997) 1441-1449
18. 4] (l = nicotinic or i-nicotinic acid) on anxiety and memory in rats. Neurochem. Res. 31 (2006) 1457-1462
19. Zanette F., Victor E.G., Scaini G., Di-Pietro P.B., Cardoso D.C., Cristiano M.P., Dal-Pizzol F., Paula M.M.S., and Streck E.L. Modulation of creatine kinase activity by ruthenium complexes. J. Inorg. Biochem. 101 (2007) 267-273
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-267
21. Fischer J.C., Ruitenbeek W., Berden J.A., Trijbels J.M., Veerkamp J.H., Stadhouders A.M., Sengers R.C., and Janssen A.J. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 153 (1985) 23-26
22. Rustin P., Chrethien D., Bourgeron T., Gerard B., Rotig A., Saudubray J.M., and Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 228 (1994) 35-51
23. Kratz F., Hartmann M., Keppler B., and Messori L. The binding properties of two antitumor ruthenium(III) complexes to apotransferrin. J. Biol. Chem. 269 (1994) 2581-2588
24. Hamman B.L., Bittl J.A., Jacobus W.E., Allen P.D., Spencer R.S., Tian R., and Ingwall J.S. Inhibition of creatine kinase reaction decrease the contractile reserve of isolated rat hearts. Am. J. Physiol. 269 (1995) 1030-1036
25. Veksler V., and Ventura-Clapier R. In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies. Mol. Cell. Biochem. 133/134 (1994) 287-298
26. Kammermeier H. High energy phosphate of the myocardium: concentration versus free energy change. Basic Res. Cardiol. 82 (1987) 31-3336
27. Van-Deursen J., Heerschap A., Oerlemans F., Ruitenbeek W., Jap P., Ter-Laak H., and Wieringa B. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74 (1993) 621-631
28. Bragadin M., Toninello A., Mancon M., and Manente S. The interactions of cobalt(II) with mitochondria from rat liver. J. Biol. Inorg. Chem. 12 (2007) 631-635
29. Bragadin M., Cima F., Ballarin L., and Manente S. Irgarol inhibits the synthesis of ATP in mitochondria from rat liver. Chemosphere 65 (2006) 1898-1903
30. Thadhani R., Pascual M., and Bonventre J.V. Acute renal failure. N. Engl. J. Med. 334 (1996) 1448-1460
31. Navarro A., and Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292 (2007) 670-686
32. Menezes C.S., Costa L.C., Ávila V.M., Ferreira M.J., Vieira C.U., Pavanin L.A., Homsi-Brandeburgo M.I., Hamaguchi A., and Silveira-Lacerda E.P. Analysis in vivo of antitumor activity, cytotoxicity and interaction between plasmid DNA and the cis-dichlorotetraammineruthenium(III) chloride. Chem. Biol. Interact. 167 (2007) 116-124
33. Sava G., Pace S., Bergamo A., Cocchietto M., Mestroni G., and Alessio E. Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition. Chem. Biol. Interact. 95 (1995) 109-126